Palliative treatment of locally advanced, non-metastatic hormone dependent prostate cancer.
Adjuvant treatment of metastatic hormone dependent prostate cancer.
Adjuvant treatment to radio therapy in patients with high risk localized or locally advanced prostate cancer.
Treatment of endometriosis
